These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

414 related items for PubMed ID: 16845643

  • 1. HPA axis activity in patients with panic disorder: review and synthesis of four studies.
    Abelson JL, Khan S, Liberzon I, Young EA.
    Depress Anxiety; 2007; 24(1):66-76. PubMed ID: 16845643
    [Abstract] [Full Text] [Related]

  • 2. Respiratory irregularity and stress hormones in panic disorder: exploring potential linkages.
    Abelson JL, Khan S, Lyubkin M, Giardino N.
    Depress Anxiety; 2008; 25(10):885-7. PubMed ID: 17557312
    [Abstract] [Full Text] [Related]

  • 3. Cognitive modulation of the endocrine stress response to a pharmacological challenge in normal and panic disorder subjects.
    Abelson JL, Liberzon I, Young EA, Khan S.
    Arch Gen Psychiatry; 2005 Jun; 62(6):668-75. PubMed ID: 15939844
    [Abstract] [Full Text] [Related]

  • 4. A striking pattern of cortisol non-responsiveness to psychosocial stress in patients with panic disorder with concurrent normal cortisol awakening responses.
    Petrowski K, Herold U, Joraschky P, Wittchen HU, Kirschbaum C.
    Psychoneuroendocrinology; 2010 Apr; 35(3):414-21. PubMed ID: 19913360
    [Abstract] [Full Text] [Related]

  • 5. Hypothalamic-pituitary-adrenal axis activity in panic disorder. 24-hour secretion of corticotropin and cortisol.
    Abelson JL, Curtis GC.
    Arch Gen Psychiatry; 1996 Apr; 53(4):323-31. PubMed ID: 8634010
    [Abstract] [Full Text] [Related]

  • 6. Dissociation between ACTH and cortisol response in DEX-CRH test in patients with panic disorder.
    Petrowski K, Wintermann GB, Kirschbaum C, Bornstein SR.
    Psychoneuroendocrinology; 2012 Aug; 37(8):1199-208. PubMed ID: 22277728
    [Abstract] [Full Text] [Related]

  • 7. Effects of the cortisol synthesis inhibitor metyrapone on the response to carbon dioxide challenge in panic disorder.
    Belgorodsky A, Knyazhansky L, Loewenthal U, Arbelle J, Cohen H, Benjamin J.
    Depress Anxiety; 2005 Aug; 21(3):143-8. PubMed ID: 16001448
    [Abstract] [Full Text] [Related]

  • 8. [The neuroendocrinology of stress and the pathophysiology and therapy of depression and anxiety].
    Ströhle A.
    Nervenarzt; 2003 Mar; 74(3):279-91; quiz 292. PubMed ID: 12627245
    [Abstract] [Full Text] [Related]

  • 9. CO2 challenge results in hypothalamic-pituitary-adrenal activation in healthy volunteers.
    van Duinen MA, Schruers KR, Maes M, Griez EJ.
    J Psychopharmacol; 2005 May; 19(3):243-7. PubMed ID: 15888509
    [Abstract] [Full Text] [Related]

  • 10. Impact of loudness dependency of auditory evoked potentials on the panic response to CCK-4.
    Eser D, Leicht G, Baghai T, Pogarell O, Schüle C, Karch S, Nothdurfter C, Rupprecht R, Mulert C.
    J Psychiatr Res; 2009 Jan; 43(4):393-400. PubMed ID: 18534623
    [Abstract] [Full Text] [Related]

  • 11. Hypothalamic-pituitary-adrenal axis activity in panic disorder: effects of alprazolam on 24 h secretion of adrenocorticotropin and cortisol.
    Abelson JL, Curtis GC, Cameron OG.
    J Psychiatr Res; 1996 Jan; 30(2):79-93. PubMed ID: 8816303
    [Abstract] [Full Text] [Related]

  • 12. Progressive dysregulation of autonomic and HPA axis functions in HIV-1 clade C infection in South India.
    Chittiprol S, Kumar AM, Satishchandra P, Taranath Shetty K, Bhimasena Rao RS, Subbakrishna DK, Philip M, Satish KS, Ravi Kumar H, Kumar M.
    Psychoneuroendocrinology; 2008 Jan; 33(1):30-40. PubMed ID: 17993249
    [Abstract] [Full Text] [Related]

  • 13. Salivary cortisol in panic: are males more vulnerable?
    van Duinen MA, Schruers KR, Jaegers E, Maes M, Griez EJ.
    Neuro Endocrinol Lett; 2004 Oct; 25(5):386-90. PubMed ID: 15580175
    [Abstract] [Full Text] [Related]

  • 14. Stress responsive neurohormones in depression and anxiety.
    Ströhle A, Holsboer F.
    Pharmacopsychiatry; 2003 Nov; 36 Suppl 3():S207-14. PubMed ID: 14677081
    [Abstract] [Full Text] [Related]

  • 15. Assessment of HPA-axis function in posttraumatic stress disorder: pharmacological and non-pharmacological challenge tests, a review.
    de Kloet CS, Vermetten E, Geuze E, Kavelaars A, Heijnen CJ, Westenberg HG.
    J Psychiatr Res; 2006 Sep; 40(6):550-67. PubMed ID: 16214171
    [Abstract] [Full Text] [Related]

  • 16. Hypothalamic-pituitary-adrenal axis activity in panic disorder: prediction of long-term outcome by pretreatment cortisol levels.
    Abelson JL, Curtis GC.
    Am J Psychiatry; 1996 Jan; 153(1):69-73. PubMed ID: 8540595
    [Abstract] [Full Text] [Related]

  • 17. Lack of specific association between panicogenic properties of caffeine and HPA-axis activation. A placebo-controlled study of caffeine challenge in patients with panic disorder.
    Masdrakis VG, Markianos M, Oulis P.
    Psychiatry Res; 2015 Sep 30; 229(1-2):75-81. PubMed ID: 26243374
    [Abstract] [Full Text] [Related]

  • 18. Similarities in hypothalamic-pituitary-adrenal axis activity between patients with panic disorder and those experiencing external stress.
    Kathol RG, Noyes R, Lopez A.
    Psychiatr Clin North Am; 1988 Jun 30; 11(2):335-48. PubMed ID: 3047703
    [Abstract] [Full Text] [Related]

  • 19. Cortisol as an indicator of hypothalmic-pitituary-adrenal axis dysregulation in patients with panic disorder: a literature review.
    Jakuszkowiak-Wojten K, Landowski J, Wiglusz MS, Cubała WJ.
    Psychiatr Danub; 2015 Sep 30; 27 Suppl 1():S445-51. PubMed ID: 26417813
    [Abstract] [Full Text] [Related]

  • 20. Effects of propranolol on symptom and endocrine responses to pentagastrin.
    Khan S, Liberzon I, Abelson JL.
    Psychoneuroendocrinology; 2004 Oct 30; 29(9):1163-71. PubMed ID: 15219640
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.